Detection of inducible resistance to clindamycin in cutaneous isolates of Staphylococcus spp. by phenotypic and genotypic methods;Detección de resistencia inducible a clindamicina en aislados cutáneos de Staphylococcus spp. por métodos fenotípicos y genotípicos

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 25, Issue 2, 2007, Pages 77-81

  Merino Díaz, Laura ^a   De La Casa, Angel Cantos ^a   Torres Sánchez, María José ^b   Aznar Martín, Javier ^a,b  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Clindamycin; Inducible resistance; Staphylococcus spp.

Indexed keywords

CLINDAMYCIN; LINCOSAMIDE; MACROLIDE; STREPTOGRAMIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; DNA MODIFICATION; EFFUSION; GENETIC ANALYSIS; GENOTYPE; NONHUMAN; PHENOTYPE; REAL TIME POLYMERASE CHAIN REACTION; STAPHYLOCOCCUS;

EID: 33847632117     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: 10.1157/13098567     Document Type: Article

References (21)

1. Leclercq R. Mechanisms of resistance to macrolides and lincosamides: Nature of the resistance elements and their clinical implications. Clin Infect Dis. 2002;34:482-92.
2. Roberts MC, Sutcliffe J, Courvalin P, Jensen LB, Rood J, Seppala H. Nomenclature for macrolide-lincosamide-streptogramin B resistance determinants. Antimicrob Agents Chemother. 1999;43:2823-30.
3. Jorgensen JH, Crawford SA, McElmeel ML, Fiebelkorn KR. Detection of inducible clindamycin resistance of staphylococci in conjunction with performance of automated broth susceptibility testing. J Clin Microbiol. 2004;42:1800-2.
4. Panagea S, Perry JD, Gould FK. Should clindamycin be used as treatment of patients with infections caused by erythromycin-resistant staphylococci? J Antimicrob Chemother. 1999;44:577-82.
5. Fokas S, Fokas S, Tsironi M, Kalkani M, Dionysopouloy M. Prevalence of inducible clindamycin resistance in macrolide-resistant Staphylococcus spp. Clin Microbiol Infect. 2005;11:337-40.
6. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; sixteenth informational supplement. M100-S16. Wayne: Clinical and Laboratory Standards Institute; 2006.
7. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved standard, 9 th ed.M2-A9. Wayne: Clinical and Laboratory Standards Institute; 2006.
8. Drinkovic D, Fuller ER, Shore KP, Holland DJ, Ellis-Pegler R. Clindamycin treatment of Staphylococcus aureus expressing inducible clindamycin resistance. J Antimicrob Chemother. 2001;48:315-6.
9. Levin TP, Suh B, Axelrod P, Truant AL, Fekete T. Potential clindamycin resistance in clindamycin-susceptible, erythromycin-resistant Staphylococcus aureus: Report of a clinical failure. Antimicrob Agents Chemother. 2005;49:1222-4.
10. Fiebelkorn KR, Crawford SA, McElmeel ML, Jorgensen JH. Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J Clin Microbiol. 2003;41:4740-4.
11. Steward CD, Raney PM, Morrell AK, Williams PP, McDougal LK, Jevitt L, et al. Testing for induction of clindamycin resistance in erythromycin-resistant isolates of Staphylococcus aureus. J Clin Microbiol. 2005;43:1716-21.
12. Martineau F, Picard FJ, Lansac N, Ménard C, Roy PH, Ouellette M, et al. Correlation between the resistance genotype determined by multiple PCR assays and the antibiotic susceptibility patterns of Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother. 2000;44:231-8.
13. Schmitz FJ, Petridou J, Milatovic D, Verhoef J, Fluit A, Schwarz S. In vitro activity of new ketolides against macrolide-susceptible and - resistant Staphylococcus aureus isolates with defined resistance gene status. J Antimicrob Chemother. 2002;49:573-84.
14. Schreckenberger PC, Ilendo K, Ristow K. Incidence of constitutive and inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci in a community and a tertiary care hospital. J Clin Microbiol. 2004;42:2777-9.
15. Delialioglu N, Aslan G, Ozturk C, Baki V, Sen S, Emekdas G. Inducible clindamycin resistance in staphylococci isolated from clinical samples. Jpn J Infect Dis. 2005;58:104-6.
16. Hamilton-Miller JMT, Shah S. Patterns of phenotypic resistance to the macrolide-lincosamide-ketolide-streptogramin group of antibiotics in staphylococci. J Antimicrob Chemother. 2000;46:941-9.
17. Jenssen WD, Thakker-Varia S, Dubin DT, Weinstein MP. Prevalence of macrolides-lincosamides-streptogramin B resistance and erm gene classes among clinical strains of staphylococci and streptococci. Antimicrob Agents Chemother. 1987;31:883-8.
18. Murphy E. Nucleotide sequence of ermA, a macrolide-lincosamide- streptogramin B determinants in Staphylococcus aureus. J Bacteriol. 1985;162:633-40.
19. Lina G, Quaglia A, Reverdy M, Leclercq R, Vandenesch F, Etienne J. Distribution of genes encoding resistance to macrolides, lincosamides, and streptogramins among staphylococci. Antimicrob Agents Chemother. 1999;43:1062-6.
20. Eady EAJ, Ross I, Tipper JL, Walters CE, Cove JH, Noble WC. Distribution of genes encoding erythromycin ribosomal methylases and an erythromycin efflux pump in epidemiologically distinct groups of staphylococci. J Antimicrob Chemother. 1993;31:211-7.
21. Tait-Kamradt A, Davies T, Appelbaum PC, Depardieu F, Courvalin P, Petitpas J, et al. Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America. Antimicrob Agents Chemother. 2000;44:3395-401.